| Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009 JA Gallego, J Bonetti, J Zhang, JM Kane, CU Correll Schizophrenia research 138 (1), 18-28, 2012 | 371 | 2012 |
| Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis JP Zhang, JA Gallego, DG Robinson, AK Malhotra, JM Kane, CU Correll International Journal of Neuropsychopharmacology 16 (6), 1205-1218, 2013 | 360 | 2013 |
| Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia DK Sarpal, DG Robinson, T Lencz, M Argyelan, T Ikuta, K Karlsgodt, ... JAMA psychiatry 72 (1), 5-13, 2015 | 311 | 2015 |
| White matter development in adolescence: diffusion tensor imaging and meta-analytic results BD Peters, PR Szeszko, J Radua, T Ikuta, P Gruner, P DeRosse, ... Schizophrenia bulletin 38 (6), 1308-1317, 2012 | 243 | 2012 |
| Safety and tolerability of antipsychotic polypharmacy JA Gallego, J Nielsen, M De Hert, JM Kane, CU Correll Expert opinion on drug safety 11 (4), 527-542, 2012 | 217 | 2012 |
| Baseline striatal functional connectivity as a predictor of response to antipsychotic drug treatment DK Sarpal, M Argyelan, DG Robinson, PR Szeszko, KH Karlsgodt, M John, ... American Journal of Psychiatry 173 (1), 69-77, 2016 | 204 | 2016 |
| Schizophrenia polygenic risk score as a predictor of antipsychotic efficacy in first-episode psychosis JP Zhang, D Robinson, J Yu, J Gallego, WW Fleischhacker, RS Kahn, ... American Journal of Psychiatry 176 (1), 21-28, 2019 | 152 | 2019 |
| White matter changes associated with antipsychotic treatment in first-episode psychosis PR Szeszko, DG Robinson, T Ikuta, BD Peters, JA Gallego, J Kane, ... Neuropsychopharmacology 39 (6), 1324-1331, 2014 | 138 | 2014 |
| Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice CU Correll, JA Gallego Psychiatric Clinics 35 (3), 661-681, 2012 | 137 | 2012 |
| Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior CU Correll, L Shaikh, JA Gallego, J Nachbar, V Olshanskiy, T Kishimoto, ... Schizophrenia research 131 (1-3), 58-62, 2011 | 114 | 2011 |
| A randomized comparison of aripiprazole and risperidone for the acute treatment of first-episode schizophrenia and related disorders: 3-month outcomes DG Robinson, JA Gallego, M John, G Petrides, Y Hassoun, JP Zhang, ... Schizophrenia bulletin 41 (6), 1227-1236, 2015 | 106 | 2015 |
| Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis JA Gallego, EA Blanco, S Husain-Krautter, EM Fagen, P Moreno-Merino, ... Schizophrenia research 202, 64-71, 2018 | 90 | 2018 |
| Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning AE Lyall, O Pasternak, DG Robinson, D Newell, JW Trampush, ... Molecular psychiatry 23 (3), 701-707, 2018 | 88 | 2018 |
| Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis JP Zhang, DG Robinson, JA Gallego, M John, J Yu, J Addington, M Tohen, ... Schizophrenia bulletin 41 (6), 1248-1255, 2015 | 85 | 2015 |
| In vivo microRNA detection and quantitation in cerebrospinal fluid JA Gallego, ML Gordon, K Claycomb, M Bhatt, T Lencz, AK Malhotra Journal of Molecular Neuroscience 47, 243-248, 2012 | 82 | 2012 |
| Time to treatment response in first episode schizophrenia: should acute treatment trials last several months? JA Gallego, DG Robinson, SM Sevy, B Napolitano, J McCormack, ... The Journal of clinical psychiatry 72 (12), 1691, 2011 | 76 | 2011 |
| Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment N Toteja, JA Gallego, E Saito, T Gerhard, A Winterstein, M Olfson, ... International Journal of Neuropsychopharmacology 17 (7), 1095-1105, 2014 | 69 | 2014 |
| A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo … DG Robinson, JA Gallego, M John, LA Hanna, JP Zhang, ML Birnbaum, ... Schizophrenia research 204, 295-303, 2019 | 67 | 2019 |
| Relationship between duration of untreated psychosis and intrinsic corticostriatal connectivity in patients with early phase schizophrenia DK Sarpal, DG Robinson, C Fales, T Lencz, M Argyelan, KH Karlsgodt, ... Neuropsychopharmacology 42 (11), 2214-2221, 2017 | 63 | 2017 |
| Relationship of cognition to clinical response in first-episode schizophrenia spectrum disorders JW Trampush, T Lencz, P DeRosse, M John, JA Gallego, G Petrides, ... Schizophrenia bulletin 41 (6), 1237-1247, 2015 | 56 | 2015 |
Anil MalhotraZucker School of MedicineVerified email at northwell.edu
